AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and CCO Dell Faulkingham sold $29K of Akebia Therapeutics, Inc.
Sold$28,515
$2.16Price
13,184Shares
−7%Stake
What AKBA did after the filing
- The stock from Thu, Mar 3 open, $2.47
- −78.2%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Apr 14 close.
Traded Mon, Feb 28. Filed Wed, Mar 2, 4:10 PM ET, after the close. Returns use the Mar 3 open and the Apr 14 close. Not investment advice.